Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_3

17%

Ph not_applicable

67%

Ph phase_2

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 2Efficacy & side effects

1(16.7%)

Phase 3Large-scale testing

1(16.7%)

N/ANon-phased studies

4(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Other(1)

Detailed Status

Completed5

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 21 (16.7%)

Phase 31 (16.7%)

N/A4 (66.7%)

Trials by Status

unknown117%

completed583%

Recent Activity

0 active trials

Showing 5 of 6

completedphase_3

Colonoscopy or Fecal Occult Blood Test in Screening Healthy Participants for Colorectal Cancer

NCT00102011

completednot_applicable

Clinical Trials (6)

Showing 6 of 6 trials

NCT00102011Phase 3

Colonoscopy or Fecal Occult Blood Test in Screening Healthy Participants for Colorectal Cancer

Completed

NCT00058032Not Applicable

CA125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women

Completed

NCT00039312Not Applicable

Comparison of Screening Tests in Detecting Cervical Neoplasia

Completed

NCT00103363Phase 2

Sputum Cytology in Screening Heavy Smokers For Lung Cancer

Completed

NCT00033488Not Applicable

Screening Women at High Genetic Risk for Ovarian Cancer

Completed

NCT00006087Not Applicable

Chest X-Ray or Chest CT Scan in Patients at High Risk of Developing Lung Cancer

Unknown

All 6 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 6